Genes polymorphism as risk factor of recurrent urolithiasis: a systematic review and meta-analysis.
BMC Nephrol
; 24(1): 363, 2023 12 08.
Article
em En
| MEDLINE
| ID: mdl-38066480
INTRODUCTION: Urolithiasis is one of the most prevalent diseases worldwide. Its prevalence is rising, both in developing and developed countries. It is known that genetic factors play big roles in the development of urolithiasis. One of the suspected factors is gene polymorphism. This study aims to find an accurate estimate of the association between genetic polymorphism and the risk of recurrent urolithiasis. METHODS: A systematic review and meta-analysis were performed on 12 studies from 3 databases that investigated gene polymorphism as an risk factor of urolithiasis. The review was done using Review Manager® version 5.3. RESULTS: Insignificant heterogenicity was found in this study. Populations from Asia and the Middle East are more likely to experience recurrent urolithiasis. Additionally, variation in the VDR and urokinase genes, particularly in the Asian population, increases the risk of developing recurrent urolithiasis. CONCLUSIONS: Gene polymorphisms have significant roles in the development of urolithiasis, especially in the Middle Eastern region.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Polimorfismo Genético
/
Urolitíase
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article